Detalhe da pesquisa
1.
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
Br J Cancer
; 130(4): 682-693, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177660
2.
Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.
Br J Cancer
; 126(8): 1186-1195, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132238
3.
NRG1 fusions in breast cancer.
Breast Cancer Res
; 23(1): 3, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413557
4.
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.
Breast Cancer Res Treat
; 188(2): 465-476, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097174
5.
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.
J Cell Sci
; 127(Pt 4): 788-800, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24363449
6.
Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubbles.
Genome Res
; 21(4): 525-34, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21252201
7.
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes.
J Pathol
; 227(4): 446-55, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22514011
8.
Single-molecule analysis of genome rearrangements in cancer.
Nucleic Acids Res
; 39(13): e85, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21525129
9.
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.
JAMA Netw Open
; 6(7): e2325332, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490292
10.
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes.
BMC Genomics
; 13: 719, 2012 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23260012
11.
Are breast cancers driven by fusion genes?
Breast Cancer Res
; 14(2): 303, 2012 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22424054
12.
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Front Oncol
; 12: 856132, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35419282
13.
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
J Clin Oncol
; 40(22): 2408-2419, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658506
14.
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non-small cell lung cancer.
Eur J Cancer
; 132: 211-223, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32388065
15.
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.
PLoS One
; 15(6): e0234302, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525942
16.
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression.
J Thorac Oncol
; 15(3): 383-391, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843682
17.
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(23): 6242-6253, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859654
18.
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923908
19.
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.
Clin Cancer Res
; 26(1): 242-255, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585938
20.
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914040